Volume: 11 Issue: 1
Year: 2023, Page: 55-62, Doi: https://doi.org/10.47799/pimr.1101.09
Received: May 22, 2022 Accepted: July 12, 2022 Published: July 12, 2022
Introduction: Mucormycosis is a very rare saprophytic, opportunistic fungal infection with high morbidity and mortality. With the Covid-19 pandemic, there is a sudden increase in the incidence of this disease due to causes not clearly known.
Methods: Retrospective clinic-radiological analysis of a series of seven microbiologically confirmed cases of Covid-19 associated mucormycosis (CAM) treated at our tertiary care center in 2021 was done.
Results: All patients were middle-aged with a mean age of 47 years. All patients had poor glycemic control. Three patients were on oxygen support and were given steroids during Covid-19 treatment. Symptoms were facial pain, swelling, headache, eyelid swelling, and nasal block. All patients underwent contrast MRI to study the extent of tissue involvement. MRI helped in complete surgical debridement with minimal deformity.
Conclusion: Judicious use of immunosuppressants and strict glycemic control vital during covid-19 treatment. Contrast MRI is the investigation of choice to identify the extent of involvement in surgical planning.
Keywords: Imaging, Covid-19, Mucormycosis, Amphotericine
Satish, D, Joy, D & Balasubramanya, Ross A . Mucormycosis co-infection associated with global COVID-19: a case series from India. Int J Otorhinolaryngol Head Neck Surg 2021:815–820.
Pranave, P, KSHIRSAGAR, RAJESH ASHOK, SARDESHMUKH, AMRUTA, WARADE, PRATIK & MISHRA, PRASAMITA . 2021. Post COVID-19 Mucormycosis in Immunocompromised Individuals with Uncontrolled Diabetes Mellitus: A Series of Seven Cases. Journal of Clinical & Diagnostic Research 15(11).
Jindal, G, Sethi, A, Bhargarva, K, Sethi, S, Mittal, A & Singh, U . 2022. Imaging findings in invasive rhino-orbito-cerebral mucormycosis in post-COVID-19 patients. Baylor University Medical Center Proceedings 35(1):32–34.
Mishra, N, Mutya, Vss, Thomas, A, Rai, G, Reddy, B & Mohanan, A A . 2021. A case series of invasive mucormycosis in patients with COVID-19 infection. Int J Otorhinolaryngol Head Neck Surg 7:867–70.
Patel, D D, Adke, S, Badhe, P V, Lamture, S, Marfatia, H & Mhatre, P . 2022. COVID-19 associated Rhino-Orbito-Cerebral Mucormycosis: Imaging spectrum and Clinico-radiological correlation- a single Centre experience. Clinical Imaging 82:172–178.
Honavar, S G . 2021. Code mucor: Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol 69:1361–1366.
Sen, M, Lahane, S, Lahane, T P, Parekh, R & Honavar, S G . 2021. Mucor in a viral land: A tale of two pathogens. Indian J Ophthalmol 69:244–52.
Kashkouli, M B, Abdolalizadeh, P, Oghazian, M, Hadi, Y, Karimi, N & Ghazizadeh, M . 2019. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Br J Ophthalmol 103:1460–1465.
Han, Q & Escott, E J . 2019. The black turbinate sign, a potential diagnostic pitfall:Evaluation of the normal enhancement patterns of the nasal turbinates. AJNR Am J Neuroradiol 40:855–61.
Zayet, Souheil, Zaghdoudi, Aida, Ammari, Lamia, Kilani, Badreddine & Benaissa, Hanene Tiouiri . 2021. Cerebro-rhino-orbital mucormycosis and aspergillosis coinfection in a patient with diabetes mellitus: a case report. IDCases 23:e01022.
Yang, J-K, Lin, S-S, Guo, Ji X-J & L-M . 2010. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 47:193–202.
Riad, A, Shabaan, A A, Issa, J, Ibrahim, S, Amer, H & Mansy, Y . 2021. COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors. J. Fungi 7:837.
Prashanth S, Handi P, Prathap N, Shoorshetty Manohar R, Bhaskarn K. Imaging in Covid-19 associated mucormycosis: a case series. Perspectives in Medical Research. 2023;11(1):55-62 DOI: 10.47799/pimr.1101.09